IMPROVEMENT OF INTERNUCLEAR OPHTHALMOPARESIS IN MULTIPLE SCLEROSIS WITH DALFAMPRIDINE

被引:9
|
作者
Serra, Alessandro [1 ,2 ,3 ]
Skelly, Margaret M. [1 ]
Jacobs, Jonathan B. [1 ,3 ]
Walker, Mark F. [1 ,3 ]
Cohen, Jeffrey A. [4 ]
机构
[1] Louis Stokes Vet Affairs Med Ctr, Daroff DellOsso Lab, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA
关键词
D O I
10.1212/WNL.0000000000000567
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:192 / 194
页数:3
相关论文
共 50 条
  • [1] Improvement of Internuclear Ophthalmoparesis in a Multiple Sclerosis Patient Taking Dalfampridine
    Serra, Alessandro
    Downey, Deborah
    Jacobs, Jonatan
    Walker, Mark
    Leigh, R. John
    [J]. NEUROLOGY, 2013, 80
  • [2] Dalfampridine for the Treatment of Internuclear Ophthalmoparesis and Ocular Motor Fatigue in Multiple Sclerosis
    Serra, A.
    Chisari, C. G.
    Jacobs, J. B.
    Skelly, M. M.
    McCabe, J.
    Abboud, H.
    Walker, M. F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 157 - 158
  • [3] Patterns of ocular motor fatigue in internuclear ophthalmoparesis due to multiple sclerosis
    Serra, A.
    Chisari, C. G.
    Jacobs, J. B.
    Matta, M.
    Skelly, M. M.
    Walker, M. F.
    Cohen, J. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 861 - 861
  • [4] Insights into ocular motor fatigue in internuclear ophthalmoparesis due to multiple sclerosis.
    Serra, Alessandro
    Chisari, Clara G.
    Jacobs, Jonatan B.
    Matta, Manuela
    Skelly, Margaret M.
    Walker, Mark F.
    Cohen, Jeffrey A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 71 - 72
  • [5] The prevalence of internuclear ophthalmoparesis in a population-based cohort of individuals with multiple sclerosis
    Hof, S. N.
    Loonstra, F. C.
    de Ruiter, L. R. J.
    van Rijn, L. J.
    Petzold, A.
    Uitdehaag, B. M. J.
    Bijvank, J. A. Nij
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
  • [6] The evolution of internuclear ophthalmoparesis in multiple sclerosis: a one year follow-up study
    Hof, S. N.
    Molenaar, P. C. G.
    Bijvank, J. A. Nij
    Lam, K. H.
    van Rijn, L. J.
    Petzold, A.
    Killestein, J.
    Uitdehaag, B. M. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 735 - 735
  • [7] DALFAMPRIDINE IN MULTIPLE SCLEROSIS
    Goodman, A. D.
    Hyland, M.
    [J]. DRUGS OF TODAY, 2010, 46 (09) : 635 - 639
  • [8] Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score
    Frohman, EM
    Frohman, TC
    O'Suilleabhain, P
    Zhang, H
    Hawker, K
    Racke, MK
    Frawley, W
    Phillips, JT
    Kramer, PD
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (01): : 51 - 55
  • [9] Evaluation of saccades show ocular-motor fatigue in internuclear ophthalmoparesis due to multiple sclerosis
    Jacobs, Jonathan B.
    Serra, Alessandro
    Chisari, Clara
    Skelly, Margaret
    Matta, Manuela
    Walker, Mark
    Cohen, Jeffrey
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [10] A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis
    Jacobs, Jonathan B.
    Chisari, Clara
    Skelly, Margaret M.
    Walker, Mark F.
    Serra, Alessandro
    [J]. MATHEMATICAL MODELLING IN MOTOR NEUROSCIENCE: STATE OF THE ART AND TRANSLATION TO THE CLINIC. GAZE ORIENTING MECHANISMS AND DISEASE, 2019, 249 : 329 - 344